Nutriband Inc. Share Price & Technical Analysis
NTRB · $3.48 (-4.40%)
Healthcare / Biotechnology
$3.48
-4.40%
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products in the United States. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. It also develops AVERSA bu…
Price chart
Seasonality
May has 2 positive and 3 negative years (last 5 years shown)
-8% return in May, 9% avg return in past 3 year May month.
-18% return in 2026, 25% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 7% | -8% | -17% | 8% | -8% | – | – | – | – | – | – | – | -18% |
| 25 | 73% | -9% | -10% | 13% | -11% | -4% | -9% | -11% | 15% | -4% | -27% | -8% | 8% |
| 24 | 8% | -7% | 73% | -27% | 59% | -4% | 11% | -33% | 49% | 2% | -23% | 0% | 108% |
| 23 | 0% | 8% | -20% | 0% | -22% | 7% | 30% | -20% | -19% | -12% | 14% | -8% | -42% |
| 22 | -51% | -8% | 6% | -6% | 18% | -10% | 33% | -5% | -5% | 16% | -9% | -8% | -29% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Neutral
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products in the United States. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. It also develops AVERSA buprenorphine and AVERSA methylphenidate, and other transdermal pharmaceutical products. The company has commercial development and clinical supply agreement with Kindeva Drug Delivery. The company was incorporated in 2016 and is headquartered in Orlando, Florida.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$43.76M
P/E ratio
—
52W high
$11.68
52W low
$3.40
Volume
25,029
Beta
1.93
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Nutriband Inc. share price today?
- Nutriband Inc. (NTRB) last traded around $3.48 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does NTRB have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for NTRB. Download the app for real-time alerts.
- How can I analyze Nutriband Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.